RETA earnings call for the period ending May 13, 2020.
News & Analysis: Reata Pharmaceuticals, Inc.
RETA earnings call for the period ending December 31, 2019.
Reata Pharmaceuticals Just Raised $505 Million to Treat Orphan Diseases: What it Means for Investors
The capital sets the biotech up nicely to launch two successful drugs.
RETA earnings call for the period ending September 30, 2019.
A drug trial showed promise in treating a particularly stubborn disease.
Keeping up with the news from major medical meetings has become a requirement for healthcare investors.
The company reclaimed rights to several promising drug candidates last week; this week, positive data from a pivotal clinical trial sent it soaring.
Earnings results and favorable comments lifted several stocks.
Data from a phase 2 study looks promising.
RETA earnings call for the period ending June 30, 2019.